Tag: Wall Street

Browse our exclusive articles!

Sam Altman Explains Why OpenAI is Not Ready for Public Market

OpenAI CEO, Sam Altman, is hesitant to take the company public due to concerns of being sued by the public market and Wall Street. As AI develops superintelligence, it may make decisions that investors find strange. Although other tech firms plunge into AI, OpenAI has raised $10 billion from Microsoft at a $30 billion valuation.

3 AI Stocks to Sell and Take Profits on Now

Artificial intelligence stocks have soared in value, but it may be time for investors to consider selling. C3.ai's Q1 revenue projection fell short, while Upstart faces challenges due to hesitant banks. Nvidia's AI success made it a trillion-dollar company, but consumer spending cuts have impacted its gaming segment. Be cautious of high prices and assess long-term potential before trading. Consider taking profits while the market is rallying. Check out the full article for in-depth information.

Market for Generative AI Predicted to Reach $1.3 Trillion by 2032 Thanks to ChatGPT

Generative AI market is projected to reach $1.3tn by 2032 due to customer-driven AI tools like ChatGPT & Bard. Nvidia, Amazon, and Microsoft are set to benefit.

Goldman Sachs Analysts Find AI-focused Stocks Outperform in Credit Markets

Goldman Sachs strategists found AI stocks outperform their credit peers. AI firms with strong balance sheets are set to benefit as demand for generative AI grows.

C3.ai (AI) Stock Experiences 11% Dip Today

C3.ai (NYSE: AI) stock falls ahead of earnings report release. Investors keen to learn about the company's Q4 2023 financial stability and growth forecast as analysts predict losses per share of 17 cents and revenue of $71.32 million. C3.ai provides AI software solutions to businesses in healthcare, energy, finance, and more. Founded by Tom Siebel, the company has seen immense growth this year, up by 253.8%.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img